Delavaco-backed Aphria begins trading on TSX Venture Exchange
Aphria Inc, a portfolio company of Canadian private equity firm Delavaco Group, has begun trading on the TSX Venture Exchange under the ticker symbol "APH". The listing followed the combination of Aphria with Black Sparrow Capital Corp. Based in Leamington, Ontario, the company is a producer, supplier and marketer of medical marijuana. In June, Vic Neufeld, the former president and CEO of Jamieson Laboratories Ltd, became the CEO and founding investor in Aphria. Delavaco at the same time provided an equity investment and $6.2 million private placement to the company.
8 December 2014•4 mins read
